Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEvaxion Biotech A/S Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q3 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2025 | 1 | -$12.50 | -$12.50 | -$12.50 |
| Q1 2026 | 2 | -$29.41 | -$0.59 | -$15.00 |
| Q2 2026 | 1 | -$14.67 | -$14.67 | -$14.67 |
| Q3 2026 | 1 | -$16.83 | -$16.83 | -$16.83 |
| Q4 2026 | 1 | -$14.67 | -$14.67 | -$14.67 |
| Q1 2027 | 1 | -$16.33 | -$16.33 | -$16.33 |
| Q2 2027 | 1 | -$15.00 | -$15.00 | -$15.00 |
| Q3 2027 | 1 | -$13.33 | -$13.33 | -$13.33 |
| Q4 2027 | 1 | -$13.17 | -$13.17 | -$13.17 |
| Q1 2028 | 1 | -$13.00 | -$13.00 | -$13.00 |
| Q2 2028 | 1 | -$10.75 | -$10.75 | -$10.75 |
| Q3 2028 | 1 | -$9.50 | -$9.50 | -$9.50 |
| Q4 2028 | 1 | -$8.00 | -$8.00 | -$8.00 |
| Q1 2029 | 1 | -$5.48 | -$5.48 | -$5.48 |
| Q2 2029 | 1 | -$1.27 | -$1.27 | -$1.27 |
| Q3 2029 | 1 | -$1.57 | -$1.57 | -$1.57 |
| Q4 2029 | 1 | -$1.96 | -$1.96 | -$1.96 |
| Q1 2030 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2030 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2030 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2030 | 1 | -$0.01 | -$0.01 | -$0.01 |
Evaxion Biotech A/S Earnings Date And Information
Evaxion Biotech A/S last posted its earnings results on Thursday, August 14th, 2025. The company reported $-0.76 earnings per share for the quarter, missing analysts' consensus estimates of $-0.5 by $0.26. The company had revenue of 7.49 M for the quarter and had revenue of 3.34 M for the year. Evaxion Biotech A/S has generated $-10 earnings per share over the last year ($-9.8 diluted earnings per share) and currently has a price-to-earnings ratio of -12.5. Evaxion Biotech A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based on prior year's report dates.
Evaxion Biotech A/S Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 2025 | N/A | $4.20 | N/A | $9.20 M | $7.49 M |
| 08/14/2025 | Q2 2025 | -$0.50 | -$4.40 | -3.9 | $7.50 M | $37.00 K |
| 03/31/2025 | Q1 2025 | N/A | -$1.43 | N/A | N/A | $0 |
| 04/01/2025 | Q4 2024 | N/A | -$3.40 | N/A | N/A | $122.00 K |
| 09/30/2024 | Q3 2024 | N/A | -$1.40 | N/A | $123.33 K | $3.02 M |
| 06/30/2024 | Q2 2024 | N/A | -$4.60 | N/A | $52.00 K | $154.00 K |
| 08/14/2024 | Q1 2024 | $0.10 | $1.04 | 0.94 | N/A | $51.00 K |
| 03/26/2024 | Q4 2023 | N/A | -$6.60 | N/A | N/A | $73.00 K |
| 09/30/2023 | Q3 2023 | N/A | -$8.20 | N/A | N/A | $0 |
| 08/17/2023 | Q2 2023 | N/A | -$8.40 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$9.68 | N/A | N/A | $0 |
| 04/27/2023 | Q4 2022 | N/A | -$11.40 | N/A | N/A | $0 |
| 11/13/2022 | Q3 2022 | -$17.00 | -$9.64 | 7.36 | N/A | $0 |
| 06/30/2022 | Q2 2022 | N/A | -$8.20 | N/A | N/A | $0 |
| 03/31/2022 | Q1 2022 | N/A | -$10.00 | N/A | N/A | $0 |
| 03/31/2022 | Q4 2021 | N/A | -$15.44 | N/A | N/A | $0 |
| 09/30/2021 | Q3 2021 | N/A | -$10.92 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$14.40 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$9.20 | N/A | N/A | $0 |
| 04/07/2021 | Q4 2020 | N/A | -$10.52 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Evaxion Biotech A/S Earnings: FAQ's
Evaxion Biotech A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based offlast year's report dates.
The conference call for Evaxion Biotech A/S's latest earnings report can be listened to online.
The conference call transcript for Evaxion Biotech A/S's latest earnings report can be read online.
Evaxion Biotech A/S (:EVAX) has a recorded annual revenue of $3.34 M.
Evaxion Biotech A/S (:EVAX) has a recorded net income of $-10,567,000.Evaxion Biotech A/S has generated $-9.8 earnings per share over the last four quarters.
Evaxion Biotech A/S (:EVAX) has a price-to-earnings ratio of -12.5 and price/earnings-to-growth ratio is -6.75.